Urinary thrombomodulin levels were significantly higher following occupational exposure to chemicals, in the presence of dipstick protein, but not in the presence of dipstick blood by Ruddock, Mark W. et al.
Urinary thrombomodulin levels were significantly higher
following occupational exposure to chemicals, in the presence of
dipstick protein, but not in the presence of dipstick blood
Ruddock, M. W., De Matos Simoes, R., O'Rourke, D., Duggan, B., Stevenson, M., O'Kane, H. F., ... Williamson,
K. E. (2015). Urinary thrombomodulin levels were significantly higher following occupational exposure to
chemicals, in the presence of dipstick protein, but not in the presence of dipstick blood. Biology and Medicine,
8(1), [1000260]. DOI: 10.4172/0974-8369.1000260
Published in:
Biology and Medicine
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
 © 2015 Ruddock MW, et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the
original author and source are credited.
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
Research Article Open Access
Biology and Medicine
Ruddock et al., Biol Med (Aligarh)  2015, 8:1
http://dx.doi.org/10.4172/0974-8369.1000260
Volume 8 • Issue 1 • 1000260
Biol Med (Aligarh)
ISSN: 0974-8369 BLM, an open access journal 
Keywords: Thrombomodulin; Smoking; Bladder cancer; Urine; 
Chemical exposure; Occupation 
Abbreviations: CE: Chemical Exposure; UC: Urothelial Cancer; 
NCE: No Chemical Exposure; CTL: Control; TURB: Trans Urethral 
Resection of the Bladder; FDR: False Detection Rate; ; CRP: C-reactive 
Protein; IL-4: Interleukin-4; TM: Thrombomodulin; MCP-1: Monocyte 
Chemo Attractant Protein 1; MMP9NGAL: Matrix Metalloproteinase 
Neutrophil Gelatinase Associated Lipocalin Complex; BPE: Benign 
Prostate Enlargement; MNI: Non- muscle Invasive; MI: Muscle Invasive
Introduction
Currently, there are no biomarkers which can identify patients who 
have an increased risk of developing UC as a result of occupational 
exposure to chemicals. Chemical exposure remains a significant risk 
factor for urothelial cancer (UC) in developed countries despite the 
laws which limit occupational exposure to harmful chemicals. This is 
attributable to both the latency periods that often exceed 20 years [1-3], 
and the significant range of chemical agents associated with increased 
risk of bladder cancer [3-7]. Recent evidence suggests that metal workers, 
car mechanics, plumbers [8], those exposed to intermediates in rubber 
and plastics manufacture [9], and those working in occupations allied 
to agriculture or medicine and health [10] could be at risk of developing 
UC. With respect to aromatic amines, risk is highest in those exposed 
at a younger age, those with over 10 years of exposure [11] and amongst 
certain categories of painters [12]. Polycyclic aromatic hydrocarbons 
arising from incomplete combustion of carbon fuels can increase 
bladder cancer risk, e.g. in those exposed to diesel fumes [13] and 
amongst asphalt pavers [14]. Dermal absorption and inhalation of oils, 
fumes and metals may be one reason for the significantly increased risk 
of bladder cancer reported for employees who have worked for over 20 
years on the assembly line in a car factory [15].  Smoking is regarded as 
the most significant risk factor for UC. Smokers are at least three times 
more likely to develop UC and their risk increases with increased pack-
years of cigarette smoking [16,17]. However, the association between 
smoking and prognosis in patients diagnosed with UC is unclear [18]. 
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Abstract
Currently, there are no biomarkers which can identify patients with an increased risk of developing urothelial cancer 
as a result of occupational chemical exposure. The aim of this study was to evaluate the relationships between final 
diagnosis and 22 biomarkers measured in urine, serum and plasma collected from 156 hematuric patients. Fourteen 
of the 80 patients (17.5%) with urothelial cancer and 13/76 (17.1%) of the controls were deemed to have a history 
of chemical exposure. We applied Fisher's exact tests to explore associations between chemical exposure and final 
diagnosis, and tumor stage and grade, where applicable; ANOVA and t-test to compare age across patients with and 
without chemical exposure; and Zelen’s exact test to evaluate relationships across final diagnosis, chemical exposure 
and smoking. Following pre-selection of biomarkers using Lasso, we identified biomarkers with differential levels across 
patients with and without chemical exposure using Welch’s t-test. Using a one-sided t-test and considering multiple 
testing using FDR, we observed that TM levels in urine were significantly higher in samples from patients with a history 
of chemical exposure regardless of their diagnosis as control or urothelial cancer (one-sided t-test, pUC = 0.014 and pCTL = 
0.043); in the presence of dipstick protein and when urinary pH levels ≤ 6 (p = 0.003), but not in the presence of dipstick 
blood (p = 0.115). Urothelial cancer patients with a history of chemical exposure were significantly younger (64.1 years) 
than those without chemical exposure (70.2 years) (one-sided t-test p-value = 0.012); and their tumors were higher 
grade (Fisher’s exact test; p = 0.008). There was a strong association between a history of chemical exposure and 
smoking in urothelial cancer patients (Zelen’s exact test; p = 0.025). Elevated urinary thrombomodulin levels could have 
the potential to identify chemical exposure in hematuric patients at high risk of developing urothelial cancer.
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Material and Methods 
Patients
One hundred and fifty-six patients with haematuria were recruited 
from Belfast City and Craigavon Area Hospitals to a case-control study, 
conducted according to Standards for the Reporting of Diagnostic 
accuracy studies guidelines, between November 2006 and October 2008. 
The study was approved by the Office for Research Ethics Committees 
Northern Ireland (ORECNI 80/04), reviewed by hospital review boards 
and registered (ISRCTN registry – 30128). The inclusion criteria were 
1) patients with haematuria who have undergone cystoscopy; and 2)
patients must be able to understand the study procedures and willing 
to give informed consent. The exclusion criteria were 1) patients who 
have not had a flexible cystoscopy; 2) patients who did not present with 
haematuria; 3) patients with UTI destined to undergo TURB; and 4) 
patients currently suffering from clinically evident alcoholism and or 
drug dependency. After written informed consent, a clean catch/mid-
stream specimen of urine voided into a sterile collecting container (~50 
ml), serum (2 ml) and plasma (2 ml) samples were collected from each 
patient and stored at -80oC until analysis [19]. Patients (98%) were 
recruited during normal working hours. 
Chemical exposure
Occupations that were classed as high risk included painters [12], 
dye workers [20], foundry workers [7], hair dressers [21], lorry drivers 
[22], miners, metal workers, concierges and janitors [23]. Patients with 
no occupational risk and no known history of exposure to chemicals 
were assigned as “no chemical exposure” (NCE). 
Biomarker analysis
Biomarker analyses (n = 22) in urine, serum and plasma were carried 
out as described previously. Briefly, scientists blinded to patient data, 
carried out the analysis of biomarkers at Randox Laboratories Ltd, County 
Antrim, Northern Ireland, using biochip array technology (BAT) (Randox 
Evidence © and Randox Investigator©) and ELISA, as previously reported. 
All analysis was carried out in triplicate (mean ± SD) [19]. 
Pathology diagnostic review
Following approval from the Northern Ireland Biobank (NIB13-
0065), DOR (Consultant Pathologist), undertook a diagnostic review 
of 20 patients with UC; 12 who were assigned as CE and eight who were 
assigned as NCE. 
Statistical analyses
We undertook the following analyses: Fisher's exact tests to explore 
the associations between CE, diagnosis and tumor stage and grade; 
ANOVA, prior to t-test, to investigate age within UC and control (CTL) 
subpopulations across CE and NCE; and Zelen’s exact test [24] using 
the NSM3 R package [25] to explore the three way association across fi-
nal diagnosis (UC vs CTL), chemical exposure (CE vs NCE) and smok-
ing (non-smoker vs smoker). 
Associations between biomarker levels and CE
We pre-selected biomarkers with non-zero coefficients using Lasso 
in conjunction with the glmnet function in the R package [26,27], 
and repeated the selection on 100 bootstrap datasets.. The minimal λ 
(0.03636) was chosen by a 10 fold cross-validation procedure. Levels 
of the pre-selected biomarkers were log10 transformed prior to analyses 
for differential levels across the CE and NCE subpopulations and across 
dipstick urine analyses categories.  We considered multiple 
testing applying the false discovery rate (FDR). 
Results
Chemical risk across UC and control patients
Twenty-seven of the 156 patients (17%) were assigned as CE. 
Fourteen of these patients had UC (52%) with the following stages: pTa 
UC (n = 5), pT1 UC (n = 6), pT3a (n = 1), pT3b (n = 1) and pT4a 
(n = 1). Thirteen of these patients (48%) were CTLs. The occupational 
histories for the patients assigned as CE are detailed in Table 1.
Higher tumor grade in patients with a history of chemical ex-
posure
Grade 1 (n = 4) and grade 2 tumors (n = 39) were combined (n 
= 43) for comparison to grade 3 tumors (n = 35). There was a signifi-
cant association between grade and CE (Fisher’s one sided exact test p 
= 0.008). The proportion of grade 1 and 2 tumors combined for NCE 
UC patients was 40/64 (63% (CI 51% to 74%)) in comparison to 3/14 
(21% (CI 0% to 42%)) for CE UC patients; none of the UC patients with 
a history of chemical exposure had Grade 1 tumors (Table 2). 
Younger age of UC patients with a history of chemical expo-
sure
UC patients with a history of CE were significantly younger (me-
dian = 64 years (IQR 59 to 71)) than NCE UC patients (median = 71 
years (IQR 65 to 76)) (ANOVA; p < 0.001) (t-test; p = 0.012). Further, 
there was no statistically significant difference in age when CE CTL and 
NCE CTL patients were compared; both groups had an average age of 
54 years (Table 2). 
The relationship between CE and smoking across controls 
and UC patients 
The proportion of patients with CE who also smoked (13/14, 93%) 
was significantly higher in the UC subpopulation in comparison to the 
CTL subpopulation (4/13, 31%) (p=0.00122). The odds ratios of UC 
patients with CE who also smoked (odds ratio = 5.18) were higher in 
comparison to the odds ratio in the CTL subpopulation (odds ratio = 
0.32) (p = 0.025, Zelen's test). It is noteworthy that the associations of 
smoking and CE were not significant when assessed independently 
for CTL (p1=0.062) and UC (p2=0.08) patients.
Biomarkers with differential expression across CE vs NCE pa-
tients 
Four urinary biomarkers, i.e. C-reactive protein (CRP), interleu-
kin-4 (IL-4), Thrombomodulin (TM), and IL-2 together with plasma 
biomarkers, monocyte chemo attractant protein 1 (MCP-1) and matrix 
metalloproteinase neutrophil gelatinase associated lipocalin complex 
(MMP9NGAL) were pre-selected using Lasso. Urinary IL-2, and the 
two plasma biomarkers, MCP-1 and MMP9NGAL, were less stable 
(bootstrap ≤ 0.11) than the three urinary biomarkers TM, CRP and 
IL-4 (bootstrap ≥ 0.34). Urinary TM was the only biomarker that was 
differentially expressed across the NCE and CE subpopulations (mean 
NCE = 4.5 ng/ml; mean CE = 6.8 ng/ml) (Welch’s t-test; p = 0.002). 
Further, urinary TM was significantly higher in CE patients across both 
subpopulations, i.e. UC (mean NCE = 4.5 ng/ml; mean CE = 7.1 ng/ml) 
(one-sided t-test; p = 0.014) versus CTL (mean NCE = 4.5 ng/ml; mean 
CE = 6.2 ng/ml) (one-sided t-test; p = 0.043) groups demonstrating that 
the differential expression was independent of UC.
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patient which was reviewed as a pT2G3. Carcinoma in situ (CIS) and
lymphovascular invasion were observed in 3/4 (75%) biopsies [29] with 
micropapillary features (Figure 1). Notably these three patients had
smoked for more than 10 years. Eight of the 12 CE patients (66%) had
recurrences, four of which were higher grade/stage disease (Table 3).
There was no evidence of micropapillary features in the biopsies 
from the eight patients with NCE and no recurrences were recorded for 
these patients. However, 2/8 (25%) of these patients had tumors which 
displayed a nested pattern (Table 4).
Discussion
TM is a glycoprotein expressed on the surface of endothelial cells, 
on the membranes of the transitional epithelium and in the cytoplas-
mic region of umbrella cells [30]. Positive TM immunoreactivity has 
been shown to have an inverse correlation with cancer progression and 
metastasis [31,32]. Previously, we reported that the immunodetection 
of cytoplasmic membrane-bound TM in UC, squamous cell carcinoma 
and adenocarcinoma formalin fixed paraffin embedded tissue microar-
rays was independent of grade and stage. Furthermore, TM immunos-
taining was significantly stronger in the UC tissue sections with respect 
Diagnosis Present Occupation Past occupation(s)
UC Timber yard – painter /sprayer Supervisor - Hardware Store  
UC Retired Car painter
UC Retired Marine engineer   
UC Retired              Landscape contractor               
UC Retired Lorry driver/agricultural sprayer
UC Engineering-mechanical Engineer
UC Retired Process operator - car manufacture
UC Retired Fireman
UC Production worker
UC Retired Lorry driver
UC Retired Service engineer  
UC Retired Mechanical engineer          
UC Unemployed Cable joiner
UC Retired School caretaker/ tyre making
control Retired Road service maintenance      
control Retired Building - skilled labourer
control Retired Foreman – works ministry   
control Window blind  fitter        Fabric factory – mixed dye
control Retired             Newspaper - production photographer   
control Recreation  park  - attendant  Coal man
control Taxi driver Moulding factory 
control Retired Carpet cleaner  
control Clergyman TV technician/ RAF radio inspector  
control Joiner
control Warehouse Plastics manufacturer             
control Lorry driver Car mechanic/car valeting
control Retired Labourer
Each patient’s occupational history was reviewed by three authors (MR, CR and KW) 
and assigned low risk (score 1), moderate risk (score 2), or high risk (score 3). 
Scores were averaged. Patients deemed to have an occupational history asso-
ciated with a high risk of bladder cancer; or patients reporting that they had been 
exposed to chemicals, passive smoking, weed-killers, dyes, paints, leather, metal, 
rubber, vehicle oils/fumes or other described carcinogens were assigned as CE.  
Table 1: Occupational histories for CE patients.
Thrombomodulin levels were higher in patients with a histo-
ry of chemical exposure
Using a one-sided t-test and considering multiple testing using 
FDR, we observed that TM levels in urine were significantly higher in 
CE patients, in the presence of dipstick protein and when urinary pH 
levels ≤ 6 (p = 0.003), but not in the presence of dipstick blood (p = 
0.115). TM levels corrected using creatinine (p = 0.029) were signifi-
cantly higher in patients with a history of chemical exposure. TM and 
creatinine levels measured in urine were significantly correlated (Pear-
son correlation; r = 0.72, p < 0.001). For the remaining biomarkers r = 
< 0.5 (Pearson correlation).
Micropapillary variant of UC in patients with a history of 
chemical exposure
Interestingly, there were features of the micropapillary variant of 
UC [28] in the four biopsies available for review from 3 patients with a 
history of CE. The first biopsy from one of these patients was a pT2G1 
tumor which displayed micropapillary features. Further, micropapil-
lary and nested patterns were observed in the recurrence from the same 
CTL UC Total(% cohort)
NCE CE NCE CE
63 13 66 14
Age
Age (mean (SD)) 54.3 (19.1) 54.1 (16.7) 70.2 (8.1)** 64.1 (8.4)*
Final diagnosis (% column)
(% 
column)
(% 
column)
(% 
column)
No diagnosis 27 (42.9)  9 (69.2) 0 0 36 (37.5)
Benign pathologies   5 (  7.9) 1 (7.7) 0 0   6 (  3.8)
Stones and 
inflammation 15 (23.8) 1 (7.7) 0 0 16 (10.3)
BPE 10 (15.9)  2 (15.4) 0 0 12 (  7.7)
Other cancers   6 (  9.5) 0 0 0   6 (  4.2)
NMI UC 0 0 51 (77.3) 11 (78.6) 62 (39.7)
MI UC 0 0 15 (22.7)  3 (21.4) 18 (11.5)
Grade 1/2 UC  40 (62.5)   3 (21.4) 43 (27.5)
Grade 3 UC  24 (37.5) 11 (78.5)** 35 (22.4 )**
Dipstick blood
-ve 23 (36.5) 5 (38.5) 12 (18.2) 3 (21.4) 43 (25.6)
+ 13 (20.6) 5 (38.5) 24 (36.4) 2 (14.3) 44 (28.2)
++ 9 (14.3) 0 4 (6.0)      1 ( 7.1) 14  ( 9.0)
+++ 17 (27.0) 3 (23.0) 22 (33.3) 5 (35.7) 47  (30.1)
++++ 1 (  1.6) 0 4 (6.0) 3 (21.4)   8  ( 5.0)
Smoking
Smokers  37 (58.7)   4 (30.8)       47 (71.2)   13 (92.9) 101 (64.7)
Smoking years 
(mean (SD)) 26.0 (16.2) 21.3 (8.5)
    35.4 
(14.5) 37.4 (9.6) N/A
TM (ng/ml) (mean) 4.5 6.2*** 4.5 7.1***
*UC patients with CE were significantly younger than UC patients with NCE.**UC 
patients with CE had higher grade tumors than UC patients with NCE. ***patients
with CE had significantly higher levels of urinary TM than NCE patients.
Table 2: Patient characteristics (n = 156).
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Figure 1: Micropapillary features in an urothelial tumour from a patient with 
a history of CE.Micropapillary variant UC exhibits surface micropapillary 
features and small clusters of tumor cells that lack a fibrovascular core (x40 
magnification). The patient had a cystoprostatectomy 10 weeks after initial 
transurethral resection of the bladder tumor. There was no residual tumor.  The 
patient has recovered very well. (Scale bar 20 µm).
to both adenocarcinoma and SCC sections which stained weakly [33]. 
TM expression has also been shown to be increased in the transitional 
epithelium in patients with cystitis [32].
Although increased levels of plasma TM are considered to reflect 
endothelial damage [34], the physiological significance of soluble TM 
in UC is unknown [35]. TM is shed into the circulation following its 
proteolytic cleavage from endothelial surfaces and increased TM lev-
els have been associated with endothelial dysfunction [36]. Endothe-
lial shedding is common in patients with hypertension, hypercholes-
terolemia, diabetes, atherosclerotic disease, and in chronic smokers 
[35,37]. Further, TM has anti-inflammatory properties and is known 
to increase during inflammatory conditions [38]. It is therefore con-
ceivable that by-products from CE could potentially induce endothelial 
shedding or irritation within the bladder which could result in an in-
creased level of urinary TM. 
 While health and safety regulations may limit occupational expo-
sure to harmful chemicals, related cases of bladder cancer remain high 
as the latency period for cancer development after exposure may be as 
long as 20 years [20]. Similarly to our findings of aggressive UC tumors 
in those exposed of chemicals, Noon et al. [20] reported that patients 
exposed to crack detection dye penetrants normally present with high-
grade tumors with associated panurothelial carcinogenesis, in contrast 
to most UC which are unifocal and low grade.
In our study, urinary TM was the only biomarker that was differ-
entially expressed across the NCE and the CE subpopulations. Urinary 
TM levels were significantly higher in CE patients, in the presence of 
dipstick protein, but not in the presence of dipstick blood. Further-
more, UC patients with a history of both smoking and CE tended to 
have more aggressive tumours, and at a significantly younger age, in 
comparison to UC patients with no history of CE. 
There is a need for new approaches to identify patients who are at 
risk of serious disease. Urinary TM may be a novel biomarker that could 
be used to screen patients in potentially ‘at risk’ occupations. Where 
levels of urinary TM levels are found to be elevated, further investiga-
tions are warranted. It should be noted that our study is limited by the 
small numbers of patients in each of the groups and our conclusions 
should be viewed in this context. As such, a larger study is required to 
validate our findings. 
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Patient Age Smoking years Grade Stage Inflammation Pattern CIS LVI
1 >60* <10
2 # TA 3 sessile absent no
2 TA 0 papillary absent no
3 TA 0 papillary present no
2 >60* >10
2 TA 0 papillary absent no
2 TA 2 papillary absent no
3 >60* >10
1 # TA 0 papillary absent no
2 TA 0 papillary absent no
4 >60 >10
2 # TA 0 papillary absent no
3 T1 2 papillary present yes
5 >60 >10 3 T1 1 micro-papillary present yes
6 <60 >10 3 T4A 1 nested absent yes
7 >60 >10
3 T2 1 micro-papillary present yes
3 T2 3
micro-
papillary 
and  
nested
present yes
8 <60 >10
0  0 papillary absent no
3 TA 0 papillary absent no
9 <60 >10
0 # TA 0 papillary absent no
1 TA 1 papillary absent no
3 TA 3 papillary absent no
10 >60 0
3 T2 1 nested absent no
3 T2 1 squamous diff absent no
11 <60 >10 3 TA 1 micro-papillary absent no
12 <60 >10 2 TA 0 papillary absent no
Table 3: Pathological review of 22 biopsies from 12 UC patients with CE. Follow-
ing approval from the Northern Ireland Biobank (NIB13-0065), DOR (Consultant 
Pathologist), undertook a diagnostic review of all tumor biopsies that were avail-
able within the Belfast City Hospital archive for each of the 12 patients with UC 
who were assigned as CE. Eight of the 12 (66%) patients with a history of CE had 
recurrences, four of which were higher grade/stage disease #.  INF inflammation: 
0 absent, 1 = +, 2 = ++, 3 = +++; LVI lymphovascular invasion*patients with incom-
plete biomarker data who were not included in the biomarker analyses
Patient Age Smoking years Grade Stage Inflammation Pattern CIS LVI
1 <60 0 3 T1 1 nested present no
2 >60 >10 CIS TIS 1 CIS present no
3 >60 0 3 T2 1 papillary absent no
4 >60 0 3 T1 1 papillary present no
5 >60 >10 3 TA 2 papillary absent no
6 >60 >10 2 TA 0 papillary absent no
7 >60 >10 3 T1 2 papillary present no
8 >60 >10 3 T3A 1 nested present yes
Table 4: Pathological review of 8 tumors from 8 UC patients with NCE. Following 
approval from the Northern Ireland Biobank (NIB13-0065), DOR (Consultant Pa-
thologist), undertook a diagnostic review of all tumor biopsies that were available 
within the Belfast City Hospital archive for each of 8 patients with UC who were 
assigned as NCE.No recurrences were recorded for the eight NCE patients.INF 
inflammation: 0 absent, 1 = +, 2 = ++, 3 = +++; LVI lymphovascular invasion
MWR and CNR are employees of Randox Laboratories Ltd who undertook 
the biomarker analyses using multianalyte biochip array technology. RdMS, FES, 
BD, MWR, CNR and KEW have been or will be named on patents: 1. Methods 
for the detection of, or risk of, bladder cancer (JWJ01571US January 2013 and 
JWJ01571GB August 2009). 2. A method of defining the likelihood of a subject 
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having bladder cancer JWJ01839GB October 2012. 3. A method for detecting 
exposure to a hazardous chemical JWJ01877GB (on going). Randox Laboratories 
Ltd paid the salary of Mr Funso Abogunrin who recruited the patients over two 
years. Invest Northern Ireland RD0412515 funded RdMS and GC.
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